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Anna P. Malykhina1*

Abstract
Background: Previously published results from our laboratory identified a mechano-gated two-pore domain potassium
channel, TREK-1, as a main mechanosensor in the smooth muscle of the human urinary bladder. One of the limitations of
in vitro experiments on isolated human detrusor included inability to evaluate in vivo effects of TREK-1 on voiding
function, as the channel is also expressed in the nervous system, and may modulate micturition via neural pathways.
Therefore, in the present study, we aimed to assess the role of TREK-1 channel in bladder function and voiding patterns in
vivo by using TREK-1 knockout (KO) mice.
Methods: Adult C57BL/6 J wild-type (WT, N = 32) and TREK-1 KO (N = 33) mice were used in this study. The overall
phenotype and bladder function were evaluated by gene and protein expression of TREK-1 channel, in vitro contractile
experiments using detrusor strips in response to stretch and pharmacological stimuli, and cystometry in unanesthetized
animals.
Results: TREK-1 KO animals had an elevated basal muscle tone and enhanced spontaneous activity in the
detrusor without detectable changes in bladder morphology/histology. Stretch applied to isolated detrusor
strips increased the amplitude of spontaneous contractions by 109% in the TREK-1 KO group in contrast to a
61% increase in WT mice (p ≤ 0.05 to respective baseline for each group). The detrusor strips from TREK-1 KO
mice also generated more contractile force in response to electric field stimulation and high potassium concentration
in comparison to WT group (p ≤ 0.05 for both tests). However, cystometric recordings from TREK-1 KO mice revealed a
significant increase in the duration of the intermicturition interval, enhanced bladder capacity and increased number of
non-voiding contractions in comparison to WT mice.
Conclusions: Our results provide evidence that global down-regulation of TREK-1 channels has dual effects on
detrusor contractility and micturition patterns in vivo. The observed differences are likely due to expression of
TREK-1 channel not only in detrusor myocytes but also in afferent and efferent neural pathways involved in
regulation of micturition which may underly the “mixed” voiding phenotype in TREK-1 KO mice.
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Background
The urinary bladder undergoes slow mechanical stretch
during the storage phase of the micturition cycle without
significant changes in intravesical pressure [5, 29]. Previous animal studies provided evidence that bladder
stretch can activate mechanosensitive two-pore domain
potassium (K2P) channels [29, 46, 49]. The family of
mechano-gated K2P channels is highly expressed in the
smooth muscle of visceral hollow organs where they
regulate smooth muscle excitability by controlling the
resting membrane potential [3, 4, 29, 52, 53]. Our previous studies confirmed that bladder capacity and detrusor
relaxation in the human urinary bladder depends on the
expression and function of TREK-1 channel, one of the
members of the K2P channel family [34]. TREK-1 has
also been detected in the human myometrium, where it
participates in the maintenance of uterine relaxation
during pregnancy [3, 10, 55]. Further, expression of
TREK-1 channels in vascular smooth muscle suggests a
role in the regulation of the vascular tone and endothelial production of nitric oxide [44, 45].
A decrease in functional expression of TREK-1 channel
in the bladder smooth muscle was shown to be associated
with detrusor overactivity (DO) in the animal model of
partial bladder outlet obstruction [4]. In humans, increased expression of TREK-1 was detected in pregnant
women’s myometrium. Interestingly, TREK-1 expression
levels declined by the time of labor [3, 10, 55]. Experimental data obtained by our group in bladder specimens from
patients with idiopathic DO confirmed a decreased expression of TREK-1 channels along with an altered response to pharmacological stimulation and diminished
smooth muscle relaxation. Additionally, DO specimens
had an increased basal tone and increased spontaneous
contractile activity suggestive that TREK-1 channels affect
bladder compliance during storage phase of the micturition cycle [48].
Limitations of in vitro experiments on isolated human
bladders included the inability to assess the full
spectrum of TREK-1 related effects on voiding function
as the channel is also expressed in the nervous system
and therefore, may indirectly participate in micturition
modulation via a neural pathway. Members of the
mechanosensitive K2P channel family are abundantly
expressed in the brain and sensory neurons of the dorsal
root ganglia in humans [18, 20, 41]. However, the studies
of functional changes in human neurons and nerve fibers have several ethical challenges making the use of
animal models necessary for this type of investigations.
Additionally, the absence of TREK-1 selective activators
and inhibitors makes it difficult to isolate TREK-1 from
other K2P channels in primary cultured cells. Therefore,
in the present study, we aimed to evaluate the effects of
TREK-1 gene knockout on bladder contractile function

Page 2 of 15

and voiding patterns by comparing wild-type (WT) and
TREK-1 KO mice. We comprehensively assessed bladder
phenotype in vivo and in vitro, measured detrusor basal
tone, spontaneous activity, contractile function and relaxation in response to nerve and muscle-mediated
stimulation of bladder smooth muscle (BSM), as well as
determined bladder responses to different pharmacological stimuli.

Methods
Animals and experimental groups

Adult male and female C57BL/6 J wild-type (WT, N = 32)
and TREK-1 knockout (Kcnk2−/−, TREK-1 KO, N = 33)
mice were used in this study. Wild type mice (10–12 weeks
old) were obtained from Jackson Laboratories (Bar Harbor,
ME, USA). TREK-1 KO mice, a generous gift from the laboratory of Dr. Min Zhou (Department of Neuroscience,
The Ohio State University, Columbus, OH), were bred in
the Breeding Core Barrier Facility at the University of Colorado Anschutz Medical Campus. Originally, the Kcnk2 −/−
mice were generated as described in [45]. Briefly, the
TREK-1 gene, Kcnk2, spans approximately 136 kbp of the
M. musculus genome and includes eight exons. The knockout mice were generated by replacing 4 kbp of the Kcnk2
gene including the second exon (excluding the first 23 bp),
the second intron, the third exon and the first 23 bp of the
third intron with a β-galactosidase/Neomycin selection cassette producing a truncated, nonfunctional protein.
All animals were housed in a regulated environment
on a 12:12-h light/dark cycle with free access to food
and water. There were no overt differences in feeding
behavior, litter size, growth rate and body weight between the WT and TREK1 KO mice. All protocols were
approved by the University of Colorado Institutional
Animal Care and Use Committee.
RT-PCR for genotyping and PKC isoform expression

Genomic
DNA
was
extracted
using
the
REDExtract-N-Amp Tissue PCR Kit (Sigma-Aldrich, St
Louis, MO. USA) from the urinary bladders of WT and
TREK-1 KO mice. Genotyping was performed as previously
described [45]. Briefly, the WT Kcnk2 allele was detected
by using the following primer pairs: forward 5′-GCTG
GGTGAAGTTCTTCAGC-3′, and reverse: 5′- CATT
ACCTGGATGAGTTCGTC-3′. The Kcnk2 KO allele was
detected using the primer pairs: forward 5′-GCAGCGCAT
CGCCTTCTATC-3′ and reverse 5′-AGGAGATGAAGACCTCTGCAAAGG-3′. End-point RT-PCR products
from WT and TREK-1 KO specimens were subsequently
run on 2% agarose gels. Gel images were taken and analyzed using the Doc-It LS Image Acquisition & Analysis
System (UVP, LLC, Upland, CA, USA).
To compare the gene expression levels of several protein kinase C (PKC) isoforms expressed in the bladder,
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whole bladder tissues were removed from WT and
TREK-1 KO mice, and snap-frozen in liquid nitrogen.
Posteriorly, total RNA was extracted and purified using
TRIzol® Plus RNA Purification Kit (Ambion, Thermo
Fisher Sci. Waltham, MA, USA) according to the manufacturer’s instructions. RNA concentrations and purity
were determined spectrophotometrically on a Nanodrop
device (Thermo Fisher Sci. Waltham, MA, USA). RNA
integrity was evaluated by formaldehyde agarose gel
electrophoresis, stained with ethidium bromide, and visualized under UV light. Isolated RNAs were stored at −
80 °C until use. First-strand complementary DNA
(cDNA) was synthesized using the Qiagen OneStep
RT-PCR kit (Qiagen, Valentia, CA. USA) by the manufacturer’s guidelines. Products were stored at − 20 °C
until the use. End-point PCR was performed using the
Qiagen Multiplex PCR plus kit (Qiagen, Valentia, CA.
USA) following the manufacturer’s instructions. The following PKC isoforms were selected for comparison due
to their significant level of expression in the urinary
bladder: PKC-α (alpha), PKC-β (beta), PKC-γ (gamma),
PKC- δ (delta), PKC-ε (epsilon), PKC-μ (mu) and PKC-τ
(tau). Primer sequences for each isoform, gene accession
numbers and predicted RT-PCR product sizes are listed
in Table 1. Non-template control reactions were included in each reaction to test for possible RT-PCR contamination and were run in parallel with the
experimental samples. End-point PCR products were analyzed by electrophoresis in 1.5% agarose gel, stained
with ethidium bromide, and visualized under UV light.
Western blotting

Total protein was isolated from the urinary bladder
by conventional tissue lysis with T-PER Tissue Protein
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Extraction Reagent (ThermoFisher Sci, Waltham, MA.
USA) containing protease and phosphatase inhibitors
(Sigma Aldrich, St Louis, MO. USA). Western blot
experiments were performed with equal loads of the
total protein per lane (20 μg). WT and KO samples
were size fractionated by SDS-PAGE electrophoresis
using 4–10% polyacrylamide Mini Protein gels
(BioRad, Hercules, CA. USA). Proteins were then
electrotransferred to polyvinylidene difluoride membranes (LICOR Biotechnology, Lincoln, NW. USA)
and incubated for one hour at room temperature
(RT) in Odyssey Blocking Buffer (TBS, LICOR Biotechnology, Lincoln, NW. USA). Membranes were
subsequently washed three times in PBST for 10 min
each and incubated with Anti-TREK-1 (F6, 1:1000,
Santa Cruz Biotechnology, Dallas, TX. USA) and
anti-Histone H3 as a house-keeping gene (1:2000,
Abcam, Cambridge, MA. USA) in blocking buffer
under constant agitation. We also tested other commercially available antibodies from the same company
which included the C20, E-19, and H-75 anti-TREK-1
variants. The C20 and E19 anti-TREK-1 antibodies
did not work for Western blotting, while H-75 antibody (aa352–426 within the C-terminus) showed two
bands in WT animals and one band in TREK-1 KO
(data not shown). Therefore, we used F6 anti-TREK-1
for Western blotting. The next day, membranes were
rinsed three times with PBST for 10 min each time,
and incubated with anti-mouse and anti-rabbit VRDye
secondary antibodies (1:10000, LICOR Biotechnology,
Lincoln, NW. USA) for 2 hrs at RT. Afterwards,
membranes were rinsed three times with PBST for 10
min each and imaged using the Odyssey CLx imaging
system (LICOR Biotechnology, Lincoln, NW. USA).

Table 1 Primers for PKC isoforms expressed in the urinary bladder
Name

Sequence

PKCα-F

AGGAGCCACAAGCAGTATTC

PKCα-R

CCAGCTTCAGATCCCTGTAAAT

PKCβ-F

GCAGAGCAAGGGCATTATTTAC

PKCβ-R

CCATCCCAGATGTTCTCCTTAC

PKCγ-F

GCACCTGAGATCATTGCCTATC

PKCγ-R

CTGTCCTGCCAACATCTCATAC

PKCδ-F

TAGTGAGGAGGAGGCAAAGT

PKCδ-R

CCGAAGAAGGTGGCGATAAA

PKCε-F

GCTCGGAAACACCCTTATCT

PKCε-R

ACATGAGGTCTCCACCATTTAC

PKCμ-F

GCAGTGGAGTTAGAAGGAGAAG

PKCμ-R

GGCTCACAGGAGACAGTAAAG

PKCτ-F

CAGGGACCTGAAGCTTGATAAT

PKCτ-R

GCATCTCCTAGCATGTTCTCTT

Fragment Size (bp)
93

114

90

Accession Number
NM_011101.3

NM_001316672.1

NM_011102.4

105

NM_001310682.1

100

NM_001310682.1

123

XM_006515590.3

96

NM_008859.2
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Tissue immunohistolabeling

WT and TREK-1 KO animals were anesthetized with
isofluorane (2.5%) and perfused via the left cardiac ventricle with phosphate-buffered-saline (PBS, pH 7.4)
followed by 4% paraformaldehyde in PBS (PFA) for 10
min. The colon, bladder, and kidneys were removed and
placed in PFA for two hours at 4o C. Subsequently; the
tissues were placed in 70% alcohol for at least 2 days before being dehydrated and embedded in paraffin. 4 μm
-thick sections were cut and mounted on “frosted” slides
(Fisher Scientific Co, Waltham, MA. USA) at the
Morphology and Phenotypic Core of the University of
Colorado Anschutz Medical Campus. Before immunolabeling, sections were washed in Xylene (Sigma-Aldrich,
St Louis, MO. USA) to remove paraffin, re-hydrated in a
graded ethanol series, washed with distilled water, and
rinsed in 50 mM Tris-buffered saline (TBS, pH 7.4) for
5 min. Heat-induced epitope retrieval was performed by
incubating the slides at 85–900 C for 15 min in Target
Retrieval Solution (DAKO, Agilent Pathology Solutions,
Santa Clara, CA. USA). Once cold down to room
temperature, the sections were washed twice in TBS
containing 0.1% Tween 20 (TBST, Sigma-Aldrich, St
Louis, MO. USA), and incubated for 30 min in casein
blocking solution (CBS, DAKO, Agilent Pathology Solutions, Santa Clara, CA. USA). Slides were incubated
overnight at 40 C (ON) in CBS with mouse monoclonal
antibodies against the TREK-1 protein (F6, 1:300; Santa
Cruz Biotechnology, Dallas, TX. USA). The next day, sections were rinsed three times with TBST for 5 min each
time, and then incubated for 2 h at RT with a secondary
antibody conjugated with Alexafluor 488-labeled
anti-mouse IgG (1:500; Fisher Scientific Co, Waltham, MA.
USA) in CBS. After incubation with secondary antibody,
sections were washed three times with TBST for 5 min
each, rinsed with TBS and counterstained with 200 nM 4′
6-diamidino-2-phenylindoledihydrochloride (DAPI, Fisher
Scientific Co, Waltham, MA. USA) in TBS for 3–5 min at
RT and rinsed twice in TBS. Coverslips were mounted with
Fluoromount-G (SoutherBiotech, Birmingham, AL. USA).
Imaging was performed on an Olympus FV1000 confocal
microscope with 40X plan-apo/1.4 numerical aperture objective and FV-viewer software (Olympus, Tokyo, JP). For
visualization, three-dimensional z-stack images of x-y
sections at 0.5 μm steps were collected. Two-dimensional
average intensity projection images were generated for analysis in FIJI (Fiji Is Image J, [50].
In vitro studies of bladder smooth muscle contractile
function

Bladder smooth muscle (BSM) strips were isolated from
WT (N = 17) and TREK-1 KO (N = 17) mice following
the previously described procedures [23, 34]. Briefly,
BSM strips (∼8–10 mg each, 2–3 mm wide and 7–8 mm
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long) were placed in individual organ baths (Radnoti
LLC, Monrovia, CA, USA), containing 7 ml of normal
Tyrode Buffer (TB, in mM: NaCl 130.0, KCl 5.0, CaCl2
1.7, MgCl2 1.0, NaH2PO4 1.3, NaHCO3 17.0, Glucose,
10.0. pH 7.4) maintained at 37 °C and equilibrated with a
constant supply of 95% O2–5% CO2. Strips were subjected to 1 h equilibration followed by determination of
the length of optimal force development (Lo). 1 μM of
tetrodotoxin (TTX, Sigma-Aldrich) was added to fresh
TB to minimize neural effects on BSM contractility. The
strips were subjected to different pharmacological treatments including either arachidonic acid (AA; 10 μM), a
TREK-1 channel agonist, or L-methionine (LM, 1 mM),
a TREK-1 channel blocker [5, 34, 42]. Untreated muscle
strips served as controls. At the end of the incubation
period, in order to assess the effects of TREK-1 channels
on stress-relaxation, all strips were subjected to an additional 30% stretch to the initially established Lo, and
allowed for complete relaxation. Following the stretch
protocol, a KCl test (bath solution was replaced with TB
containing 125 mM KCl) was performed to ensure that
the BSM could maintain the force after stretch [23, 24].
After KCl stimulation, muscle strips were washed three
times (10 min each time) in fresh TB and allowed to recover for 30 min. After recovery, all strips were incubated with a non-specific PKC activator, Phorbol
12,13-Dibutyrate (PDBu, 1 μM: Sigma; Greenwood Village, CO), for 45 min.
A separate set of experiments was performed to evaluate the contribution of active and passive basal tone
components in BSM from WT and TREK-1 KO bladders. After establishing L0 in normal Ca2+ TB, the buffer
was changed to Ca2+ free TB followed by 30 min incubation and measurements of the basal tone and spontaneous contractile activity of BSM strips. Some strips were
subjected to an additional 30% stretch to evaluate
stress-relaxation under Ca2 free conditions. At the end
of the testing protocol, all strips were treated with 2 μM
of nifedipine, an L-type Ca2+ channel blocker, to assess
the role of Ca2+ entry via voltage-gated Ca2+ channels
on BSM tone and spontaneous activity.
All BSM experiments were recorded and analyzed
using LabChart 8 Pro (AD Instruments, Colorado
Springs, CO, USA), pClamp 10 (Molecular Devices,
LLC. San Jose CA, USA) and Matlab R2014b (MathWorks, Natick, MA, USA). The following parameters
were measured and analyzed: basal muscle tone (in g/g,
g of force per g of muscle strip weight), amplitude of
spontaneous contractions (g/g, measured as amplitude
from the baseline level of each strip and normalized to
its weight), peak force (PF; in g or g/g when normalized
to the weight of the muscle strip), and integral force (IF)
which reflects how long a muscle strip can maintain the
contractile force before it starts relaxing [33].
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Urodynamic evaluation of bladder function (awake
cystometry)

Animals assigned for urodynamic evaluation of urinary
bladder function (awake cystometry) underwent a survival surgical procedure to insert bladder catheters as
previously described [35]. Briefly, the animals were anesthetized with isofluorane (VEDCO, St.. Albans, VT) and
the bladder was exposed through a lower midline abdominal incision. A polyethylene tubing (PE-50, I.D.
0.58 mm, O.D. 0.96 mm; Intramedic, Becton Dickinson.
Parsippany, NY) with a flared end was inserted through
a puncture at the bladder dome, and sutured in place
with purse string suture and 7.0 silk (Ethicon, Somerville, NJ). The catheter was then tunneled subcutaneously and exteriorized at the scapular region where it
was sutured to the skin and filled with sterile saline solution. After confirming no leakage in the bladder, the
catheter was plugged with a metal rod, and the muscle
and skin layers were closed with a 5.0 silk suture (Ethicon, Somerville, NJ). Particular care was taken not to
stretch the bladder during the procedure or to restrict
the normal bladder movement once the catheter was in
place.
Mice were allowed to recover from surgery (4–5 days)
before the urodynamic study. Unanesthetized animals
were placed in the cystometry cage, and allowed to acclimate for 30–40 min. Saline was slowly infused into the
urinary bladder at a rate of 10 μl/min, and micturition
cycles were recorded using the MED-CMG Small Animal Cystometry acquisition software (Catamount Research and Development). The following cystometric
parameters were evaluated in this study: bladder capacity, pressure at the start of micturition, micturition
rate, intravesical pressure, inter-micturition interval, and
number of non-voiding contractions. Non-voiding contractions were defined as the increased values in detrusor pressure not associated with voiding, equal or
larger than twice the mean value of baseline. The number of non-voiding contractions was measured for each
micturition cycle, and then averaged per cycle based on
the number of recorded cycles (e.g. voiding episodes)
per animal. Normal voiding contractions had amplitudes
of at least a third of maximal pressure recorded during a
single micturition event.
Statistical analyses

The results are expressed as the mean ± standard error
of the mean (SEM) with N reflecting the number of animals in each group and n being the number of recordings. Statistical significance between two groups was
assessed by the Student two-way t-test followed by a
comparison between groups using the Bonferroni’s correction. When comparing more than two groups,
one-way ANOVA with the post hoc Newman-Keuls test
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was reported (Prism 7. GraphPad Software, La Jolla, CA.
USA). Plots were made with OriginLab Data analysis
software v 7.0 (OriginLab Co. Northampton, MA). Difference between the groups and treatments was considered statistically significant at p ≤ 0.05.

Results
Genotyping of TREK-1 KO mice

In TREK-1 KO mice used for this study, the four transmembrane domains and two-pore forming regions were
genetically truncated by replacing most of exon 2 and all
exon 3 by a LacZ/Neo cassette [45]. We confirmed the
deletions by performing end-point RT-PCR in mRNA
extracted from TREK-1 KO and WT bladder tissue samples (N = 5 in each group). The WT primers were designed, as previously described, to include parts of
intron 2 and exon 3 sequences, while the KO primers included part of the LacZ/Neo cassette and intron 3 [14].
The results of RT-PCR genotyping from TREK-1 KO
and WT mice are shown in Fig. 1a. The sizes of the
bands corresponding to TREK-1 KO and WT alleles
were around ~ 200 and ~ 450 bp, respectively. Figure 1b
represents a Western Blot image of the total protein isolated from WT, and TREK-1 KO mouse bladders probed
with an anti-TREK-1 antibody showing one band ~ 50
kDa in WT but not in TREK-1 KO specimens (N = 5 in
each group). As previously reported [14, 45], no significative changes were observed in fertility, number of the
offspring or growth rate between the WT and TREK-1
KO groups.
Expression of TREK-1 in the visceral organs of WT and
TREK-1 KO mice

Immunofluorescent tissue labeling was used to compare
the presence and distribution of TREK-1 proteins in the
visceral organs of WT and TREK-1 KO mice including the
urinary bladder, colon, and kidneys. As shown in Fig. 2a
(left panel), TREK-1 was expressed in the colon of WT animals with stronger labeling present in the colonic mucosa
in comparison to the muscle staining. Intense TREK-1 immunoreactivity was also found in the muscularis mucosa
layer. In contrast, TREK-1 KO animals showed a significantly reduced TREK-1 immunoreactivity across the colonic tissue (Fig. 2a, right panel). Confocal images of the
bladder sections from WT group (Fig. 2b, left panel) displayed a homogeneous TREK-1 like staining across the detrusor with faint signal in the urothelium and serosa. In
contrast, TREK-1 KO animals showed a significant reduction in TREK-1 immunofluorescence. Histologically, the
urinary bladders showed no visible morphological alterations (Fig. 2d), and no significant differences were observed in bladder weight between WT and TREK-1 KO
animals (9.3 ± 0.7 vs. 10.2 ± 0.6 mg, respectively). The
body/bladder weight ratio (g/mg) in WT and TREK-1 KO
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A

B

Fig. 1 Genotyping of WT and TREK-1 KO mice. a Representative agarose
gel showing the amplicons of wild-type (C57BL/6 J, WT, N = 1) and TREK1 KO (KO, N = 3) alleles. The first column represents the molecular weight
marker (MW) with the following three lines corresponding to the
amplicon products generated by KO mRNA. The fourth line illustrates the
amplicon produced by WT mRNA for comparison. The size of the bands
corresponding to the TREK-1 KO (KO) and WT alleles are around ~ 200
and ~ 450 bp, respectively, as previously reported [45]. b Western
blotting of total bladder protein from WT and TREK-1 KO animals
showing a prominent band at ~ 50–52 kDa in WT mice but not in
TREK-1 KO group (KO). Histone H3 was used as loading control

mice was also similar between the groups (Fig. 2e). The
kidneys were bean-shaped, ~ 1.0 cm in length and
weighted individually 0.50 ± 0.1 g and 0.46 ± 0.1 g (WT
and TREK-1 KO groups, respectively). Histological images
taken at the cortex level showed no visible histological
changes in TREK-1 KO mice compared with WT aminals.
In WT mice, most of the tubules in the kidney nephrons
were positively labeled with TREK-1 antibody (Fig. 2c, left
panel) with very faint or no positive reaction at the glomerular level. A substantial reduction in TREK-1 immunoreactivity was observed in the kidneys from TREK-1 KO
animals (Fig. 2c, right panel).
Deficiency of TREK-1 channel is associated with increased
basal muscle tone and spontaneous contractions in the
detrusor

We next evaluated the role of TREK-1 channels in the
maintenance of the basal smooth muscle tone and spontaneous contractions in vitro. The weight of BSM strips
isolated from WT and TREK-1 KO mice and used for contractile function studies was similar between the groups
(8.0 ± 1.5 mg and 9.1 ± 2.1 mg, respectively, N = 17 and n
= 34 in each group). The basal muscle tone of the strips at
their optimal length (L0) was 50.7 ± 6.1 g/g in WT and
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71.2 ± 8.5 g/g in TREK-1 KO mice (Fig. 3 a, N = 17; n = 34
in each group, p ≤ 0.01). Application of AA caused 24% reduction in basal tone of WT muscle strips (from 50.7 ±
6.1 g/g to 38.5 ± 4.6 g/g, p = 0.025) whereas the strips from
TREK-1 KO bladders had a similar tendency in response
to AA, however, did not reach a level of statistical significance (Fig. 3a). In a different set of experiments, BSM
strips underwent 30% stretch in addition to L0 in order to
evaluate stress-relaxation of the detrusor when the bladder undergoes a significant stretch upon reaching its maximal capacity. After the stretch protocol, BSM strips from
WT mice experienced an increase in the basal tone up to
81.5 ± 7.3 g/g (58.3% to L0 level, p ≤ 0.05, Fig. 3b), whereas
the strips from TREK-1 KO mice had an increase of 50%
(from 71.2 ± 8.5 g/g to 107.2 ± 9.6 g/g, p ≤ 0.05 to L0 level).
Application of LM did not significantly affect the basal
muscle tone of the stretched strips in either group, however, incubation with AA led to 32% decrease in WT
group (N = 8, n = 8, p ≤ 0.05 to WT) without causing significant changes in TREK-1 KO group (N = 8, n = 9, Fig. 3
b). Analysis of spontaneous activity of BSM strips at L0 revealed the presence of spontaneous contractions in
TREK-1 KO group (2.2 ± 0.2 g/g, Fig. 3c, p ≤ 0.05 to WT)
in comparison to lower contractile activity in WT group
(1.3 ± 0.1 g/g, Fig. 3 c, an insert shows representative raw
traces of the spontaneous activity in both groups). Additional stretch increased the amplitude of spontaneous
contractions by 61% in WT group (Fig. 3d, p ≤ 0.05 to respective L0 level) with the amplitude of spontaneous contractions in BSM strips being doubled in TREK-1 KO
group (109% increase to respective L0, Fig. 3d).
The differences observed in the basal muscle tone and
frequency of spontaneous activity between WT and
TREK-1 KO BSM strips were further tested in Ca2+ free
TB to evaluate the role of active contractile processes due
to Ca2+ influx into the cells. First, we incubated BSM from
WT and TREK-1 KO animals in Ca-free solution for 30
min followed by either 30% additional stretch or incubation with nifedipine, a general L-type calcium channel
blocker (2 μM, 30 min). Representitave recordings from
WT and TREK-1 KO BSM strips are included in Fig. 4.
Substitution of normal TB by Ca2+-free TB reduced the
basal muscle tone in both WT and TREK-1 KO BMS
strips when compared to normal Ca2+ solution (Fig. 4a,
middle traces). However, BSM from TREK-1 KO mice
showed a ~ 2.0 fold increase in the amplitude of spontaneous contractions (from 2.2 ± 0.1 g/g in normal Ca2+ to
4.1 ± 0.1 g/g in Ca2+-free TB, N = 4,n = 8 in each group,
p ≤ 0.05 to normal Ca TB). Application of additional
stretch under Ca2+ free conditions showed decreased
values of PF in both WT and TREK-1 KO groups by ~
30–32% when compared to normal Ca2+ solution. The
contractile reponses also had a significantly faster initial
decline phase of stress-relaxation in both groups (Fig. 4b).
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Fig. 2 Comparison of morphological phenotypes and spatial distribution of TREK-1 channel in visceral organs of WT and TREK-1 KO mice. Representative
images of immunohistochemically labeled TREK-1 protein in paraffin sections obtained from WT (left panels, N = 4, n = 20) and TREK-1 KO (right panels, N
= 4, n = 20) mice. a) Colon, b) Urinary bladder, c) Kidneys. Used abbreviations: m-mucosa; cm-circular muscle; lm-longitudinal muscle; sm-smooth muscle;
rc-renal corpuscle; cd-collecting ducts; bc-Bowman’s capsule. The scale bar is 50 μm. d Trichrome staining of urinary bladder cross-sections from WT and
TREK-1 KO mice (10x). E) Body/bladder weight ratio in WT and TREK-1 KO animals

Enhanced force generation to electric field stimulation
and high potassium in BSM strips from TREK-1 KO mice

Bladder smooth muscle strips from TREK-1 KO mice generated more contractile force in response to EFS (32 Hz)
in comparison to WT group (222.2 ± 21.2 g/g and 162.2 ±
16.2 g/g, p ≤ 0.05, Fig. 5a, middle panel). The IF calculated
as ratio of the area under the curve (AUC) of a single contraction divided by its PF was also significantly higher for
TREK-1 KO group in comparison to WT (250 ± 30.1 vs
163.1 ± 19.6, p ≤ 0.05, Fig. 5a, right panel). Similar to the
effects of EFS, TREK-1 KO strips also revealed an increased contractile response to high KCl stimulation (Fig.
5b). However, application of TREK-1 inhibitor (LM) and
activator (AA) did not substantially change the contractile
responses to high potassium in both WT and TREK-1 KO
groups in comparison to baseline values (Fig. 5b).
Previous studies from our laboratory established that
PKC activation with general agonist phorbol-12,
13-dibutyrate (PDBu) significantly reduced the amplitude and increased the frequency of spontaneous BSM
contractions at low concentrations (10 nM) while causing an increase in muscle force generation at higher concentrations (1 μM). Although several previous studies

provided evidence that PKC mostly affects large conductance Ca2+-activated potassium channels (BK),
TREK-1 channels could also be modulated by PKC
phosphorylation. Therefore, we tested the reponses to a
PKC activator in TREK-1 KO bladders. Application of
PDBu (1 μM) significantly increased PF (by 50%,
p ≤ 0.05, Fig. 6a) and the amplitude of spontaneous
contractions in TREK-1 KO muscle strips when compared to WT group. Protein kinase C conveys both
calcium-dependent, and calcium-independent effects on
DSM contractility in vitro mediated via inhibition of
myosine light chain phosphatase. However, it is still unknown if these separate effects are mediated by different
PKC isoforms. Therefore, we aimed to test if elevated
reponses to PKC stimulation in TREK-1 KO bladders
may be due to compensatory changes in expression
levels of the PKC isoforms present in the detrusor. The
results of RT-PCR presented in Fig. 6b did not reveal
any significant changes in the expression levels of 7
tested PKC isoforms including (PKC-α (alpha), PKC-β
(beta), PKC-γ (gamma), PKC- δ (delta), PKC-ε (epsilon),
PKC-μ (mu) and PKC-τ (tau)) between the WT and
TREK-1 groups. This data suggests that the effects are
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Fig. 3 Increased basal tone and amplitude of spontaneous contractions in the detrusor of TREK-1 KO mice. a The basal tone of BSM strips isolated
from WT (N = 17, n = 34) and TREK-1 KO (N = 17, n = 34, KO) mice was measured at L0. Incubation with arachidonic acid (AA) significantly reduced the
basal tone in WT (WT + AA, N = 4, n = 8, p ≤ 0.05) but not in TREK-1 KO group. b Application of additional stretch (30% to L0) caused an increase in
basal tone of both WT and KO strips. No significant changes in response to TREK-1 inhibitor, L-methionine (LM), were recorded in both groups. c The
amplitude of spontaneous contractions at L0 was significantly elevated in TREK-1 KO group in comparison to WT group. The insert shows zoomed-in
raw traces from both experimental groups. d Stretch protocol increased the amplitude of spontaneous contractions in both WT and TREK-1 KO BSM
strips. * - p ≤ 0.05 to respective WT group, # - p ≤ 0.05 within the group

likely due to the secondary regulatory changes in PKC–
related signaling pathways.
Urodynamic analysis of bladder function in TREK-1 KO
mice

The analysis of cystometrograms recorded under control
conditions in WT (N = 5) and TREK-1 KO (N = 6) mice
showed an approximately 2-fold increase in bladder capacity in TREK-1 KO animals in comparison to WT mice
(210.0 ± 8.1 μl vs. 108.2 ± 8.0 μl, respectively.Figure 7 a, b
and c. p ≤ 0.05), and a significant prolongation of the
intermicturition interval (540.0 ± 43.8 s vs 1188.4 ± 166.4
s, WT and KO mice, respectively. Figure 7d. p ≤ 0.05).
The substantially elevated volume of infused saline during storage phase, which is reflective of increased bladder capacity, with the prolonged duration of the voiding
cycle point toward the development of an underactive
phenotype in TREK-1 KO mice. However, although no
differences were observed in bladder pressure at voiding

(32.1 ± 3.2 mmHg vs. 39.0 ± 2.7 mmHg, TREK-1 KO, and
WT mice, respectively), BMS from TREK-1 KO animals
showed a 2-fold increase in the number of non-voiding
contractions (TREK-1 KO: 4.5 ± 0.6 vs WT: 2.0 ± 0.5,
p ≤ 0.05, Fig. 7e) per micturition cycle. Other urodynamic characteristics were not different between the
WT and TREK-1 KO animals. Therefore, the overall
TREK-1 KO bladder phenotype displays the characteristics of both bladder under- and overactivity.

Discussion
Evaluation of bladder phenotype in TREK-1 KO animals
revealed significant differences in comparison to WT
mice including elevated basal muscle tone, increased
amplitude of basal spontaneous activity, limited pharmacological responses to TREK-1 activators and inhibitors,
and elevated contractile responses to EFS and high potassium without significant changes in bladder morphology/histology. However, urodynamic study in TREK-1
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Fig. 4 The effects of Ca2+ free solution and nifedipine on the basal muscle tone and spontaneous contractions in TREK-1 KO mice. a Representative traces
of muscle tone and spontaneous activity in BSM strips from WT (upper panels) and TREK-1 KO (lower panels) animals. b Application of additional stretch
under Ca2+ free conditions reduced the amplitude of the contractile response in both WT and TREK-1 KO animals

KO mice revealed a substantially longer intermicturition interval, enhanced bladder capacity and
increased number of non-voiding contractions in comparison to WT animals. Overall, the results of the
combined in vivo and in vitro experiments provided evidence that global down-regulation of TREK-1 channel
leads to “mixed” voiding phenotype in TREK-1 KO mice.
TREK-1 channel belongs to a family of mechanogated
two-pore domain potassium channels (K2P) that produce
background conductances, and are regulated by a variety
of stimuli (e.g., pH, temperature, stretch and lipids) to
control resting membrane potential and cell excitability
[7]. The TREK subfamily, encoded by the KCNK2 gene,
consists of three known members (TREK-1, TREK-2 and
TRAAK) which participate in diverse transduction processes including mechano-sensitivity [6, 36, 38, 47],
thermo-sensitivity [2, 26, 39], chemo-sensitivity [40],
nociception, and neuroprotection [12, 15, 20, 31].
The results of Western blotting and IHC demonstrated that TREK-1 protein was substantially diminished in the urinary bladder of TREK-1 KO mice. The
antibodies used for WB and IHC should detect any
TREK-1 protein being translated, regardless of which
one of the multiple start codons was used to initiate
translation. Since we used the TREK-1 KO strain created
by Namiranian et al. [45] in which both the second and

third exons of Kcnk2 gene were deleted, all start codons
present in both exons were deleted in this strain. Another group [17] created TREK-1 KO strain in which
only the third exon was removed leaving an alternative
start codon in exon 2, and, therefore, a truncated
TREK-1 protein could be translated. In our study, we
tested several TREK-1 antibodies. The anti-TREK-1
mouse monoclonal antibody from SantaCruz Biotechnology (F6, sc-398,449; mapped at aa354–380 near the
C-terminus of hTREK-1) showed only one band ~ 50–
52 kDa when used in WB (Fig. 1b). We also tested other
commercially available antibodies from the same company which included the C20, E-19, and H-75
anti-TREK-1 variants. The C20 and E19 anti-TREK-1
antibodies did not work for Western blotting, while
H-75 antibody (aa352–426 within the C-terminus)
showed two bands in WT animals and one band in
TREK-1 KO (data not shown) suggesting that it might
be recognizing alternatively spliced variants or “off-target” proteins.
Increased basal muscle tone in the bladder of TREK-1
KO mice supports previous suggestions about the role of
TREK-1 channel in maintaining the negative resting
membrane potential in visceral smooth muscle [45].
Bladder muscle strips from TREK-1 KO mice also revealed the presence of spontaneous activity at both
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Fig. 5 Effect of electric field stimulation and high potassium on WT and TREK-1 KO bladder detrusor strip contractile function. a Isolated BSM strips
from TREK-1 KO mice showed significantly higher contractile force in response to EFS (80 V, 32 Hz, 1 ms duration). The left panel shows overlapped
examples of raw traces from both groups. Middle panel represents the summary of PF normalized to the weight of tissue strips whereas right panel
shows the integral force for both groups. b Effect of KCl stimulation on PF in WT (N = 17, n = 34) and TREK-1 KO (N = 17, n = 34) groups before and
after pharmacological activation (by AA) and inhibition (by ML) of TREK-1 channels. Left panel represents raw traces of recordings. * - p ≤ 0.05 to
WT group

resting level and after additional stretch. Spontaneous
contractions have been previously recorded in a variety
of bladder smooth muscle types including human [21,
58], rabbit [11, 24], rat [23], guinea pig [56], pig [25, 56],
and mouse [28, 54]. It is possible that knockdown of
TREK-1 may affect calcium mobilization and modify the
threshold for smooth muscle excitability and/or contractility, thereby, increasing spontaneous activity, as observed in our study. To test this hypothesis, we
incubated BMS strips in Ca2+-free TB followed by the
application of nifedipine, a L-type calcium channel
blocker (Fig. 4). Incubation of TREK-1 KO strips in Ca2
+
− free solution effectively reduced the basal tone to the
levels similar to those observed in WT BMS strips.
Interestingly, the reduced muscle tone observed in Ca2
+
-free solution was associated with a 2-fold increase in
the amplitude of spontanous contractions in TREK-1

KO group. The total elimination of spontaneous contractions and further reduction in basal tone by nifedipine suggests that TREK-1 channels participate in
regulation of spontaneous contractions by stabilizing the
membrane potential at voltages closer to the potassium
resting potential. Overall, in addition to previously published data on human [3, 34] and animal [22, 42] visceral
smooth muscle, our data provide additional evidence
that TREK-1 channel plays a critical role in maintaining
bladder basal tone, bladder compliance and modulates
the response of the detrusor to stretch.
The contractile responses of BSM to EFS are mainly
mediated by the release of neurotransmitters from
intramural nerve terminals in the bladder wall causing
detrusor contraction. We compared the responses of
TREK-1 KO and WT muscle strips in their ability to
generate force in response to EFS. The data showed
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Fig. 6 Activation of PKC pathway in the urinary bladder is associated with higher response to stimulation in TREK-1 KO mice. a Effects of PKC
activator, PDBu (1 μM) on contractile function of WT (N = 8, n = 8) and TREK-1 KO (N = 8, n = 9, left panel) muscle strips. Right panel indicates that
PDBu induced a significant increase in PF in TREK-1 KO group when compared to WT bladders. b RT-PCR results show gene expression of 7 major PKC
isoforms expressed in the urinary bladders from both WT and TREK-1 KO mice. Bands from 1 to 7 represent the following PKC isoforms: 1 - PKC-α
(alpha), 2 - PKC-β (beta), 3 - PKC-γ (gamma), 4 - PKC- δ (delta), 5 - PKC-ε (epsilon), 6 – PKC- μ (mu), 7- PKC-τ (tau). Line 8 - GAPDH. M- marker, * - p ≤
0.05 to WT group

that the loss of TREK-1 channels was associated with
a significant increase in peak contractility in response
to EFS (Fig. 5) while slowing the rate of relaxation in
the TREK-1 KO muscle strips when compared to WT
group. While EFS induces a contraction mainly via
the release of acetylcholine from bladder nerves,
KCl-induced contractions result from direct activation
and depolarization of the detrusor muscle due to
rapid membrane depolarization and the associated influx of Ca2+ via voltage-gated Ca2+ channels. Similar
to EFS, high potassium solution also caused a significantly elevated amplitude of the contractile response
in TREK-1 KO strips suggesting that increased contractility in the absence of TREK-1 channels is due to
a partial membrane depolarization which shifts the
resting membrane potential towards more positive
values closer to the activation threshold of
voltage-gated calcium channels.

Prior studies have reported that protein kinase C
(PKC) may be able to phosphorylate TREK-1 channels in
smooth muscle, thereby, modulating the contractile
force [30, 37, 43]. We previously showed that activation
of PKC by general PKC activator, PDBu, at low levels of
stimulation could inhibit spontaneous contractions in
rabbit [24] and rat [23] BSM while higher levels of PKC
stimulation had the opposite effect. These data predict
that upon down-regulation of TREK-1, the PKC activator, PDBu, should have a more positive contractile effect
on KO muscle strips when compared to WT group. Our
data are consistent with this analysis in that PDBu,
indeed, increased both the PF and the amplitude of
spontaneous contractions in TREK-1 KO muscle strips
compared to the WT mice. Analysis of gene expression
of different PKC isoforms expressed in the urinary bladder did not reveal significant differences between WT
and TREK-1 KO mice. Therefore, additional studies will
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Fig. 7 Urodynamic evaluation of bladder function in WT and TREK-1 KO mice. a Representative cystometrogram traces recorded in freely moving
WT (upper panels) and TREK-1 KO (bottom panels) mice. The volume of the infused saline and bladder pressure are included in the
traces. b Analysis of bladder capacity (BC) in WT and TREK-1 KO groups. c Comparison of the total volume infused before micturition in
WT and TREK-KO mice. d Duration of inter-micturition interval in WT and genetically modified mice. e The average number of nonvoiding contractions (per micturition cycle) recorded in WT and TREK-1 KO mice. Zoomed-in segments of the traces indicated by squares
are shown in the inserts. * - significance level of p ≤ 0.01 to WT group

be required to evaluate if the elevated response to PKC
activation in TREK-1 KO bladder is due to the changes
in PKC phosphorylation or activation of different downstream signaling pathways.
In contrast to in vitro contractility results, the urodynamic evaluation of voiding function in vivo by
awake cystometry revealed a significant increase in
the duration of inter-micturition interval and enhanced bladder capacity, both of which usually define
an underactive bladder phenotype. Despite these
changes, the intravesical pressure during micturition
was not affected by the TREK-1 knockdown, and the
number of non-voiding contractions was almost
2-fold higher in these animals which is in line with

the increased contractility of the detrusor observed
during the in vitro studies discussed above. Taken together, these results suggest that knock-down of
Kcnk2 gene has dual or “mixed” effects on detrusor
contractility and micturition patterns. One of the possible explanations could be associated with expression
of the channel on vascular and visceral smooth
muscle cells as well as on the fibers and neurons of
the peripheral and central nervous system [19, 41].
The functional role of TREK-1 in smooth muscle cells
is mainly to contribute to the “leak” current responsible for the maintenance of hyperpolarized resting
membrane potential to keep the cells more relaxed
during resting state [5, 10].
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In the nervous system, TREK-1 was shown to control
electrogenesis, differentiation, axonal migration, synaptogenesis, and neural response to temperature and mechanical stretch [1, 9, 13, 16, 19, 27, 31, 51]. In comparison to
smooth muscle cells, where action potentials are driven by
the influx of Ca2+ via L-type Ca2+ channels, excitability of
neurons is regulated mainly by voltage-gated Na+ channels.
The lack of TREK-1 channel in neurons would shift the
resting membrane potential towards more positive values
(just like in smooth muscle cells) allowing for the rapid influx of Na+ inside the cell, and, therefore, making both afferent and efferent neurons more excitable. The final result
of this neuronal activity would depend on what neurons are
more affected by these changes. An increase in afferent activity from the urinary bladder to the brain is usually associated with an increase in urgency and frequency of
micturition associated with bladder overactivity. However,
the efferent output from the brain to the bladder is mainly
inhibitory to allow for the voluntary control of micturition.
Therefore, increased excitability of efferent neurons would
lead to increased inter-micturition interval and bladder underactivity, which we observed in our study in vivo. Future
studies focused on manipulations of either afferent or efferent neural pathways are warranted to test this hypothesis.
Another possible explanation for the differences between in vitro and in vivo bladder phenotypes could be associated with some unknown alterations occurring during
genetic modifications of the parental strain. TREK-1 was
determined to mediate changes in the actin cytoskeleton
independently of its channel activity in fetal neurons during development in a different strain of TREK-1 KO mice
[32]. The same mouse strain showed an increased efficacy
of 5-HT neurotransmission and resistance to depression
[20]. Previous studies from our [35] and other [57] groups
provided evidence that lower urinary tract function in
mice varies in a consistent manner with strain and/or sex.
For instance, voiding spot assay and cystometry performed
in male and female C57BL/6 J, 129S1/SvImJ, NOD/ShiLtJ,
and CAST/EiJ mice [8] to evaluate bladder function,
established a significantly prolonged duration of the micturition cycle in genetically modified animals (129S1/
SvImJ, NOD/ShiLtJ, and CAST/EiJ) in comparison to
C57BL/6 J strain [8]. These results are in line with our
cystometric recordings from TREK-1 KO mice. The differences between our study and the published results included the use of both sexes (males and females), the use
of WT controls which were not littermates, and performance of cystometry without anesthesia in our experiments,
as well as the absence of in vitro experiments in the previously published study.
The choice of the approach to create a genetically
modified strain also seems to affect the function of different organs and tissues in genetically modified animals.
For instance, the TREK-1 KO strain we adopted and

Page 13 of 15

used in our study, provided no evidence that TREK-1 is
involved in the regulation of arterial diameter in cerebral
arteries [45]. However, another TREK-1 KO strain [32]
did present with the vascular phenotype. There is also a
possibility that genetic knockdown of TREK-1 expression could trigger compensatory changes in other
mechano-gated ion channels or related signaling cascades, thereby, affecting the final voiding phenotype as
well as the response of the detrusor to stretch. Further
studies are warranted to address these questions.

Conclusions
Our study provided evidence that global down-regulation
of TREK-1 channels has dual effects on detrusor contractility and micturition patterns in vivo. The integrative effects of TREK-1, likely, depend on the expression and
function of the channel not only in detrusor myocytes but
also in afferent and efferent neural pathways regulating
micturition. Future studies are warranted to identify the
precise mechanisms of TREK-1 associated mechanotransduction between detrusor myocytes and afferent nerves in
the bladder wall, as well as the role of TREK-1 in efferent
fibers and central nervous system centers controlling voiding. This knowledge would provide a foundation for the
development of novel therapeutic approaches to treat
voiding dysfunction in patients with detrusor overactivity,
overactive bladder, and bladder pain syndrome.
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